期刊文献+

N-端缺失突变核糖核酸酶抑制因子在毕赤酵母中的克隆与表达

Cloning and Expressing of Deletion-Mutagenesis Ribonuclease Inhibitor in Pichia pastoris
在线阅读 下载PDF
导出
摘要 人胎盘核糖核酸酶抑制因子(HRI)是一种存在于细胞浆中的50kDa的酸性蛋白质,富含亮氨酸和半胱氨酸。作为胞浆蛋白可保护细胞不受外来的胰RNase的侵袭,同时做为RNase抑制剂在各实验室广为应用。HRI主要结构是由7个富含亮氨酸的重复序列组成,7个亮氨酸重复单位有规律环状排列使N-末端、C-末端在空间上较为接近。本文用PCR的方法在HRIcDNA5'端去除30个碱基,并将此缺失突变的HRI的cDNA片段构建于质粒pPIC9K,PCR和双酶切鉴定结果为阳性,测序结果证实在HRIcDNA5'端成功引入30个碱基的缺失突变。电击转化入毕赤酵母(Pichiapastores)GS115中,进行分泌型表达。对表达产物进行亲和层析纯化。经SDS-PAGE和Western-blot免疫印迹杂交,证实表达产物为N-端缺失突变的核糖核酸酶抑制因子。 The human placental ribonuclease inhibitor (HRI) is an acidic protein of Mr~50kDa with an amino acid composition characterized by unusually high levels of leucine and cysteine. It is a cytosolic protein that protects cells from the adventitious invasion of pancreatic-type ribonuclease. HRI is composed of 7 leucine-rich repeats units as either a circle, a helix, or a line. The circular arrangement may bring the N and C terminals into close proximity. In present paper, 5'-termini of 30 bp deletion-mutated HRI cDNA was constructed into plasmid pPIC9K to show positive clonies and then transformed Pichia pastoris GS115 by electroporation. After screening the colony, the bacterium was cultured and its product was purified with affinity chromatography. Purified HRI were examined by SDS-PAGE and Western-blot.
出处 《水产科学》 CAS 北大核心 2004年第9期19-22,共4页 Fisheries Science
关键词 核糖核酸酶抑制因子 缺失突变 毕赤酵母 ribonuclease inhibitor deletion-mutagenesis Pichia pastoris
  • 相关文献

参考文献15

  • 1[1]Lee FS,Fox EA,Zhou HM,et al. Primary structure of human placental ribonuclease inhibitor[J]. Biochemistry,1988(27):8545-8553.
  • 2[2]Hofsteenge J,Kieffer B,Matthies R,et al. Amino Acid Sequence of the Ribonuclease Inhibitor from Porcine Liver Reveals the Presence of Leucine-Rich Repeats[J]. Biochemistry,1988(27):8537-8544.
  • 3[3]Lee F S,Shapiro R,Vallee B L. Tight-Binding Inhibition of Angiogenin and Ribonuclease Inhibitor[J]. Biochemistry,1989(28):225-230.
  • 4[4]Shapiro R,Vallee BL .Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activity of angiogenin[J]. Proc Natl Acad Sci USA,1984,84(8):2238-2241.
  • 5[5]Chang-Zheng Chen and Robert Shapiro. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A[J]. Proc.Natl Acad.Sci. USA,1997(94):1761-1766.
  • 6[6]Shapiro R,Melisa RG and Cheng-zheng Chen. Analysis of the interaction of human ribonuclease inhibitor with angiogenin and Ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "Hot Spot"[J]. J.Mol.Biol,2000(302):497-519.
  • 7[7]Lee FS,Vallee BL. Modular mutagenesis of human placental ribonuclease inhibitor,a protein with leucine-rich repeats[J]. Proc.Natl Acad.Sci.USA,1990(87):1879-1883.
  • 8[8]Hofsteenge J,Vincentini A and Stone S R. Purification and characterization of truncated ribonuclease inhibitor[J].Biochem J,1991(275):541-543.
  • 9[9]Peter Blackburn. Ribonuclease Inhibitor from Human placenta: Rapid purification and Assay[J]. Biochemistry 1979.254(24):12484-12487.
  • 10[10]Cregg J M,Madden K R,Barringer KJ,et al. Function characterization of the two alcohol oxidase genes from the yeast pichia pastoris[J]. Mol Cell Biol ,1989(9):1316-1323.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部